Ms. Chou’s main collaborations have been with pediatric, colorectal surgery service and epidemiology.
Ms. Chou has worked on several survivorship studies with Dr. Moskowitz, Dr. Ford from consulting service, and Dr. Oeffinger from the department of pediatric to better understand long-term health issues related to cancer therapy among patients surviving childhood cancer. In the clinical setting, she has worked closely with Dr. Gonen and Dr. Weiser from the colorectal service to develop nomogram to predict recurrence in colon cancer. In addition, they have also developed a nomogram to predict overall survival in colon cancer using SEER public data. In Epidemiology study, she has worked with Dr. Engel in the Epidemiology Service to examine association between risk of melanoma and exposure of PCBs, and organochlorine pesticides using a nested case-control design in a large population cohort. She has also collaborated with Dr. Orlow to examine the association with clinical factors and several gene polymorphisms in melanoma patients. Finally, she has recently begun to work on a colorectal cancer prevention project with Dr. Zauber, involving the adenoma prevention with Celecoxib (APC) Placebo-controlled trial to determine the association between the level of red blood cell folate and the risk of adenoma recurrence.
Ms. Chou’s research interests include methods of survival analysis in particular with nomogram construction and validation.